Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 40883 record(s)

Req # A-2019-001626

Adverse Reaction Report (AER) for Singulair. Report number: E2B_00218368. AER for Temodal. Report numbers: 000614955, 2B_00199440, E2B_00199477. AER for Varivax II. Report number: 000629992. AER for Vasotec. Report numbers: 000625156, 000643791. AER…

Organization: Health Canada

253 page(s)
April 2020

Req # A-2019-001628

Adverse Reaction Report (AER). Report numbers: E2B_02677382, E2B_02658115.

Organization: Health Canada

24 page(s)
April 2020

Req # A-2019-001668

Adverse Reaction Report (AER). Report number: E2B_02498116.

Organization: Health Canada

11 page(s)
April 2020

Req # A-2019-001698

Adverse Reaction Report (AER). Report number: E2B_02401241.

Organization: Health Canada

12 page(s)
April 2020

Req # A-2019-001721

Adverse Reaction Report (AER) for Anagrelide. Report numbers: E2B_02706689, E2B_02706705.

Organization: Health Canada

22 page(s)
April 2020

Req # A-2019-001722

Adverse Reaction Report (AER) for Intuniv XR. Report number: 000728106.

Organization: Health Canada

2 page(s)
April 2020

Req # A-2019-001726

Adverse Reaction Report (AER) for C1 Esterase Inhibitor (Human). Report number: E2B_02753255.

Organization: Health Canada

18 page(s)
April 2020

Req # A-2019-001733

Adverse Reaction Report (AER) for ENTYVIO. Report numbers: E2B_02804437, E2B_02811901, E2B_02767323, 000730583, E2B_02801138, E2B_02791050, E2B_02808626, E2B_02777727.

Organization: Health Canada

115 page(s)
April 2020

Req # A-2019-001785

Adverse Reaction Report (AER). Report numbers: 000709858; 000711564.

Organization: Health Canada

12 page(s)
April 2020

Req # A-2019-001799

Adverse Reaction Report (AER). Report number: E2B_02738003.

Organization: Health Canada

16 page(s)
April 2020
Date modified: